Harry T. Robins

Partner

Harry T. Robins is a partner in Morgan Lewis's Antitrust Practice. Mr. Robins represents clients, including a number of prominent private equity firms and Fortune 500 companies, before the U.S. Federal Trade Commission and the U.S. Department of Justice, as well as international regulatory agencies, in connection with mergers and acquisitions and joint venture transactions.

Mr. Robins also handles litigation and counseling matters, including class action litigation and government investigations. Most recently, Mr. Robins represented HSBC in connection with the foreign currency exchange class action litigation (S.D.N.Y.), and Tolko Industries in connection with the oriented strand board class action litigation (E.D. Pa). Additionally, Mr. Robins negotiated a settlement on behalf of HSBC in a multi-defendant antitrust case that avoided any payment for damages. He was also instrumental in winning a motion to dismiss a complex tying claim involving two medical device companies (S.D.N.Y.).

Mr. Robins has had leadership roles in obtaining antitrust approvals in a number of complex transactions, including:

• On behalf of Pearson plc in connection with its joint venture of Penguin and Random House (Bertelsmann) (approvals pending)

• On behalf of General Cable in connection with its acquisition of Alcan Cable from Rio Tinto (Department of Justice)

• On behalf of Apollo Management, L.P./ Berry Plastics Corporation in connection with its acquisition of Rexam SBC, specialty and beverage closures business (Department of Justice)

• On behalf of Perrigo Inc. in connection with its acquisition of Paddock Laboratories (Federal Trade Commission)

• On behalf of Eurand B.V. in connection with its sale to Axcan Pharmaceuticals (Federal Trade Commission)

• On behalf of Pfizer Inc. in connection with its $4 billion acquisition of King Pharmaceuticals (Federal Trade Commission)

• On behalf of Smiths Interconnect (Smiths Group plc) in connection with its acquisition of Interconnect Devices Inc. (Federal Trade Commission)

• On behalf of Pfizer Inc. in connection with its $68 billion acquisition of Wyeth (Federal Trade Commission). Negotiated Consent Order that required no divestiture of any human health product.

• On behalf of Pearson plc in connection with its acquisition of Harcourt Assessment from Reed Elsevier (Department of Justice). Negotiated Consent Order that included product divestitures of less than 1% of Harcourt's gross revenue worldwide.

• On behalf of Owens Corning in connection of its acquisition of St. Gobain's glass composite business (Multi-jurisdictional approvals)

• On behalf of Progress Rail (formerly owned by One equity Partners) in connection with its sale of its FM Industries business to Amsted, Inc. (Department of Justice)

• On behalf of Performance Fibers' (Sun Capital) acquisition of Invista's European fiber business (Phase II investigation by the German Federal Cartel Office)

• On behalf of One Equity Partners (the private equity arm of JP Morgan Chase) in the United States and the European Union in connection with One Equity Partners' sale of Moneyline Telerate to Reuters plc.

Mr. Robins is often quoted with respect to issues pertaining to the Hart-Scott-Rodino Act. Most recently, he discussed FTC's proposed changes to Hart-Scott-Rodino premerger rules in Compliance Week's article "Changes Good and Bad Coming to HSR Compliance" as well as in the article "New Merger Rules: Boon or Bane?" featured in CFO. Mr. Robins is also a frequent writer and speaker on antitrust matters. He has presented at the Bond Market Association's Annual Compliance Conference on "Standard-Setting Initiatives for the Fixed Income Industry: An Antitrust Primer," and spoke at the ABA Business Law Section on "Proposed Changes to the Hart-Scott-Rodino Act Rules." In 2011, Mr. Robins presented "Mergers—Nuts & Bolts, Distribution Practices & Competitor Collaborations in the United States: Spotting the Issues for Business Lawyers" at the ABA's Annual meeting in Toronto.

Mr. Robins is admitted to practice in New York and Connecticut and before the U.S. Court of Appeals for the Second Circuit and the U.S. District Court for the Southern District of New York.